It is common knowledge that Africa has borne the brunt of the HIV/AIDS epidemic. However, debate continues in many circles about whether multinational drug companies and their executives made decisions that hurt global efforts to fight the disease at its peak. Did the big pharma companies put profits over people in their early response to the HIV/AIDS pandemic?